Stay updated on Pembrolizumab with CAPOX in Advanced BTC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with CAPOX in Advanced BTC Clinical Trial page.

Latest updates to the Pembrolizumab with CAPOX in Advanced BTC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe clinical trial record is no longer displayed; the page shows a 403 Forbidden message alongside a notice about NIH website terminology changes.SummaryDifference22%

- Check20 days agoChange DetectedA general NIH banner appeared announcing a website transition and a change in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision label also changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check34 days agoChange DetectedThe error page’s revision label updates from v3.7.0 to v3.7.1 while the study record remains unavailable.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study details with an access-denied message; users will see a generic error page instead of the ClinicalTrials.gov study content.SummaryDifference21%

- Check54 days agoChange DetectedThe bottom of the page now displays a new Revision stamp: v3.7.0, replacing the previous v3.6.6. This indicates a new build of the page but does not alter the study content or its details.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision label changed from v3.6.5 to v3.6.6, reflecting a software update. No user-visible content or study information was modified.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with CAPOX in Advanced BTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with CAPOX in Advanced BTC Clinical Trial page.